Tech Company Financing Transactions
NovaDigm Therapeutics Funding Round
NovaDigm Therapeutics, operating out of Brookline, raised $10 million in funding from private investors.
Transaction Overview
Company Name
Announced On
2/21/2013
Transaction Type
Venture Equity
Amount
$10,002,358
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1622A Beacon St. 302
Brookline, MA 02446
USA
Brookline, MA 02446
USA
Phone
Website
Email Address
Overview
NovaDigm Therapeutics is a biomedical firm developing vaccines and therapeutics for the treatment of infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Cooke
Chief Scientific Officer
John Hennessey
VP - Bus. Development
Tuomas Holmberg
Browse more venture capital transactions:
Prev: 2/21/2013: Clustrix venture capital transaction
Next: 2/21/2013: Balanced venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs